Zobrazeno 1 - 10
of 55
pro vyhledávání: '"Fang Hui"'
Autor:
Liuye Huang, Le Li, Aihui Wu, Xiaoqian Xu, Hongyun Zhang, Xuelian Zhao, Rufei Duan, Fang-Hui Zhao, You-Lin Qiao
Publikováno v:
Cancer Medicine, Vol 10, Iss 17, Pp 6078-6088 (2021)
Cancer Medicine
Cancer Medicine
Objectives To evaluate the clinical performance of liquid‐based cytology (LBC), HPV tests and visual inspections with acetic acid or Lugol's iodine (VIA/VILI) as primary screening and triage strategies among Chinese women living with HIV (WLHIV). M
Autor:
Cai-Feng Su, Shaung Zhao, Richard Muwonge, Qin-Jing Pan, Rengaswamy Sankaranarayanan, Li-Jun Du, Fang-Hui Zhao, Partha Basu, Xian-Zhi Duan, You-Lin Qiao, Shang-Ying Hu, Xun Zhang, Xuelian Zhao, Xi-E Xiang, Zhihua Liu
Publikováno v:
International Journal of Cancer. 148:1419-1427
Thermal ablation is a point-of-care ablative treatment technique for cervical intraepithelial neoplasia (CIN). However, limited information is available about its efficacy in low- and middle-income countries. We evaluated the efficacy of thermal abla
Publikováno v:
Pediatric Research. 89:1485-1491
BACKGROUND The definition of pediatric AKI continues to evolve. We aimed to find a better AKI definition to predict outcomes and identify risk factors for AKI in a Chinese PICU. METHODS This study consisted of 3338 patients hospitalized in a Chinese
Autor:
Fang-Hui Zhao, Jun-Fei Ma, Shang-Ying Hu, Xun Zhang, Remila Rezhake, Feng Chen, Qin-Jing Pan, You-Lin Qiao
Publikováno v:
Gynecologic Oncology. 156:616-623
Objective To estimate long-term outcomes of biopsy-confirmed cervical intraepithelial neoplasia grade 1 (CIN1) or normal cervix and identify the cofactors during disease progression. Methods In 1999, a cervical cancer screening cohort in Shanxi, Chin
Autor:
Changfa Xia, Remila Rezhake, Xiaoqian Xu, Shang-Ying Hu, Yan Wang, Xun Zhang, Rengaswamy Sankaranarayanan, Xuelian Zhao, You-Lin Qiao, Xian-Zhi Duan, Fang-Hui Zhao, Partha Basu
Publikováno v:
International Journal of Cancer. 147:1275-1285
Human papillomavirus (HPV) test, self-sampling and thermal ablation for cervical intraepithelial neoplasia (CIN) have been developed separately to increase screening coverage and treatment compliance of cervical cancer screening programmes. A large-s
Autor:
Shuang Zhao, Jessica Lu, Fang-Hui Zhao, Shang-Ying Hu, Feng Chen, Xian-Zhi Duan, Xuelian Zhao, Xun Zhang
Publikováno v:
Chinese Journal of Cancer Research
Objective Precise prevention is more desired for cervical cancer due to the huge population, high prevalence of human papillomavirus (HPV) infection in China and the vision of screen-and-treat strategies in low- and middle-income countries (LMICs). C
Autor:
Xuelian Zhao, Shuang Zhao, Xun Zhang, Kevin Zhao, Shang-Ying Hu, Qin-Jing Pan, Fang-Hui Zhao, Qian Zhang
Publikováno v:
The Journal of Infectious Diseases. 219:215-222
BACKGROUND Biomarkers highly predictive of cervical cancer are urgently needed for triaging human papillomavirus (HPV)-positive women. METHODS A total of 1997 women aged 35-45 years in Shanxi, China, were recruited in 1999, and follow-up visits were
Publikováno v:
Cancer Control : Journal of the Moffitt Cancer Center
Cancer Control, Vol 28 (2021)
Cancer Control, Vol 28 (2021)
Introduction: Uptake of cervical cancer screening services in Chinese migrant workers is unknown and may be lower than non-migrant workers in China. Methods: We conducted a cross-sectional study among migrant and non-migrant women aged 21-65 at 7 pro
Autor:
Karen Canfell, Maribel Almonte, E. Peeters, Chris J.L.M. Meijer, Jesper Bonde, Kate Cuschieri, Peter Hillemanns, Marc Arbyn, Nicolas Wentzensen, Joakim Dillner, Marie Simon, Anja Ostrbenk Vanlencak, Remila Rezhake, Fang-Hui Zhao, Johannes Berkhof, Mario Poljak, Silvia de Sanjosé, Lan Xu, Murat Gultekin
Publikováno v:
Arbyn, M, Simon, M, Peeters, E, Xu, L, Meijer, C J L M, Berkhof, J, Cuschieri, K, Bonde, J, Ostrbenk Vanlencak, A, Zhao, F-H, Rezhake, R, Gultekin, M, Dillner, J, de Sanjosé, S, Canfell, K, Hillemanns, P, Almonte, M, Wentzensen, N & Poljak, M 2021, ' 2020 list of human papillomavirus assays suitable for primary cervical cancer screening ', Clinical Microbiology and Infection, vol. 27, no. 8, pp. 1083-1095 . https://doi.org/10.1016/j.cmi.2021.04.031
CLINICAL MICROBIOLOGY AND INFECTION
Clinical Microbiology and Infection
CLINICAL MICROBIOLOGY AND INFECTION
Clinical Microbiology and Infection
Background Only clinically validated HPV assays can be accepted in cervical cancer screening. Objectives To update the list of high-risk HPV assays that fulfil the 2009 international validation criteria (Meijer-2009). Data Sources PubMed/Medline, Emb
Autor:
Ying Hong, Haiwen Tang, Fengcai Zhu, Shang-Ying Hu, Qin-Jing Pan, Cheng-Fu Zhang, Yuemei Hu, Xiaoping Yang, Xiaoqian Xu, Feng Chen, Fang-Hui Zhao, Dan Bi, Jia-Xi Yu, Shuang Zhao, Wen-hua Zhang, Jiahong Zhu, Yejiang Zhu, Xun Zhang, Frank Struyf, Naveen Karkada
Publikováno v:
Human Vaccines & Immunotherapeutics
article-version (VoR) Version of Record
article-version (VoR) Version of Record
Human papillomavirus (HPV) vaccines are efficacious against HPV infections and associated lesions in women HPV-naïve at vaccination. However, vaccine efficacy (VE) against oncogenic, high-risk HPV (HR-HPV) types in women infected with any other HR-H